Advertisement
Advertisement
BDSX
Biodesix, Inc. Common Stock
23.50
USDSponsored
+1.40
+6.33%
Aug 07, 15:59 UTC -4
Closed
After-Market
23.95
+0.45
+1.91%
BDSX Earnings Reports
Positive Surprise Ratio
BDSX beat 16 of 24 last estimates.
67%
Next Report
Date of Next Report
Nov 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
$28.18M
/-$0.81
Implied change from Q2 26 (Revenue/ EPS)
+4.91%
/+14.08%
Implied change from Q3 25 (Revenue/ EPS)
+29.44%
/-29.57%
Biodesix, Inc. Common Stock earnings per share and revenue
On Aug 05, 2026, BDSX reported earnings of -0.71 USD per share (EPS) for Q2 26, beating the estimate of -0.92 USD, resulting in a 22.85% surprise. Revenue reached 26.86 million, compared to an expected 26.55 million, with a 1.18% difference. The market reacted with a -2.99% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 5 analysts forecast an EPS of -0.81 USD, with revenue projected to reach 28.18 million USD, implying an increase of 14.08% EPS, and increase of 4.91% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Omada Health, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.01
Actual
$0.15
Surprise
+1,020.25%
Nutex Health Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$5.05
Actual
$9.58
Surprise
+89.59%
CryoPort, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.19
Actual
-$0.20
Surprise
-1.16%
Shoulder Innovations, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.46
Surprise
+2.85%
Embecta Corp. Common Stock
Report Date
Aug 07, 2026 For Q3 26
Estimate
$0.27
Actual
$0.56
Surprise
+107.18%
SkinHealth Systems Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.02
Actual
-$0.02
Surprise
+19.35%
Natera, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.50
Actual
-$0.47
Surprise
+6.67%
Viatris Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.61
Actual
$0.69
Surprise
+12.58%
Sotera Health Company Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.24
Actual
$0.26
Surprise
+7.62%
Establishment Labs Holdings Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.34
Actual
-$0.39
Surprise
-13.67%
FAQ
What were Biodesix, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Biodesix, Inc. Common Stock reported EPS of -$0.71, beating estimates by 22.85%, and revenue of $26.86M, 1.18% above expectations.
How did the market react to Biodesix, Inc. Common Stock's Q2 2026 earnings?
The stock price moved down -2.99%, changed from $22.78 before the earnings release to $22.10 the day after.
When is Biodesix, Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 02, 2026.
What are the forecasts for Biodesix, Inc. Common Stock's next earnings report?
Based on 5
analysts, Biodesix, Inc. Common Stock is expected to report EPS of -$0.81 and revenue of $28.18M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement